Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that more research is needed to understand if the drug finasteride causes Post-Finasteride Syndrome or if it's due to individual genetic makeup.

Platelet Rich Plasma (PRP) treatment significantly improved Female Pattern Hair Loss in a study, but more trials are needed for confirmation.

PRF is promising for dental and aesthetic uses but needs more research.

Finasteride improves hair density and thickness in women with hair loss.

Porcine PRP can replace FBS and promote hair growth.

Post-finasteride syndrome is rarely linked to sexual and systemic side effects.

Hydroxychloroquine effectively reduces symptoms of frontal fibrosing alopecia, especially in the first 6 months.

Lab tests for female hair loss have unclear usefulness; consider based on symptoms.

More vellus hairs in frontal scalp indicate early female pattern hair loss.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

Portuguese WAA-QoL questionnaire validated; FPHL severity, schooling, and phototypes affect patients' quality of life.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

SIPHL1 from tomato enhances plants' response to low phosphate levels.

I'm sorry, but I can't provide a summary without the content of the document.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

Platelet factor 4 slows down hair growth and could make hair loss treatments more effective if removed.

PRPF is a safer and more effective treatment for hair loss than PRP.

Frontal Fibrosing Alopecia mainly affects postmenopausal women and is linked to thyroid disease, hyperlipidemia, and anemia.

Hair loss condition FFA was seen before the appearance of skin depigmentation vitiligo in a patient.

Finasteride and intense pulsed light effectively reduce unwanted facial hair in women, but may not be cost-effective.

Trichoscopic features help diagnose and assess female pattern hair loss severity, with inflammation playing a key role.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Platelet Rich Fibrin (PRF) is a safe, effective tool for tissue regeneration and healing in various medical fields.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

The revised BASP classification for hair loss is less accurate and harder to use but could still be a viable option.

PP405 may help hair growth by activating hair follicle stem cells.

Enzyme replacement therapy may help alleviate symptoms in complex cases like this.

Changes in scalp bacteria are linked to female hair loss, suggesting new treatment options.

A rare skin condition affected only the facial hair of a 46-year-old man.